Imagen de Portada

Potential for inflammation biomarkers to identify risk for mental disorders

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autor principal:	Alison Knopf
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	The Brown University Child & Adolescent Psychopharmacology Update
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Loneliness in early adolescence associated with increased risk for mental disorders
por: Alison Knopf
Publicado: (2026)

Study identifies eight traumatic and ACEs to psychiatric risk across development
por: Alison Knopf
Publicado: (2024)

Psychotic‐like experiences found predictive of half of mental disorders
por: Alison Knopf
Publicado: (2026)

Inflammatory proteins during pregnancy increases risk of disorders in children
por: Alison Knopf
Publicado: (2025)

Researchers find possible biomarker for pediatric anxiety
por: Alison Knopf
Publicado: (2026)

Stress disorders increase in college students
por: Alison Knopf
Publicado: (2024)

Prescribe for patients with opioid use disorder — with confidence
por: Alison Knopf
Publicado: (2024)

Experimental, but effective: Noninvasive brain stimulation for various disorders
por: Alison Knopf
Publicado: (2024)

Treatments needed for young people with stimulant use disorders
por: Alison Knopf
Publicado: (2025)

CM management, best treatment for stimulant disorder, still on the ropes
por: Alison Knopf
Publicado: (2024)

Dopamine link between psychosis and cannabis use disorder unclear
por: Alison Knopf
Publicado: (2025)

Confidentiality, clinicians, and parents in mental health care now
por: Alison Knopf
Publicado: (2024)

Journal summary of year's adolescent mental health articles
por: Alison Knopf
Publicado: (2025)

Off‐label LAI antipsychotics effective for treating bipolar disorder in teens
por: Alison Knopf
Publicado: (2025)

Regardless of victim age, trauma increases depression risk
por: Alison Knopf
Publicado: (2025)

Psychopathology risk in mid‐adolescence increased by multiple prenatal adversities
por: Alison Knopf
Publicado: (2026)

Researchers recommend training ED physicians on suicide risks in children and teens
por: Alison Knopf
Publicado: (2024)

Researchers call for screening moms for depression before, during, and after pregnancy
por: Alison Knopf
Publicado: (2024)

What Chevron doctrine's rejection by Supreme Court could mean for SUD treatment
por: Alison Knopf
Publicado: (2024)

Recommendations call for screening before, during, and after pregnancy
por: Alison Knopf
Publicado: (2024)

Parent‐guided early intervention for preterm babies improves motor skills
por: Alison Knopf
Publicado: (2024)

Rapid initiation protocol for naltrexone for OUD
por: Alison Knopf
Publicado: (2024)

Childhood maltreatment causes suicide, depression, and more
por: Alison Knopf
Publicado: (2024)

Final rule for methadone treatment removes barriers for patients under 18
por: Alison Knopf
Publicado: (2024)

Rise in child suicide linked to reduced quality of life, parental addiction
por: Alison Knopf
Publicado: (2024)

AACAP on advocating amidst stimulant shortage
por: Alison Knopf
Publicado: (2024)

Research and clinical use of transcranial magnetic stimulation
por: Alison Knopf
Publicado: (2024)

FDA warns against accidental overdose on fentanyl patches by children
por: Alison Knopf
Publicado: (2024)

Why a complete medical exam is necessary prior to diagnosing ADHD
por: Alison Knopf
Publicado: (2024)

Importance of good sleep in helping prevent subsequent suicidal behaviors
por: Alison Knopf
Publicado: (2024)

Why physicians are reluctant to treat addiction
por: Alison Knopf
Publicado: (2024)

The Cass report, gender identity, and where to go next
por: Alison Knopf
Publicado: (2024)

ADHD medications with fewer adverse events would improve outcomes
por: Alison Knopf
Publicado: (2024)

The rise of the apps: FTC and DOJ crack down on provider selling data
por: Alison Knopf
Publicado: (2024)

SAMHSA overdose toolkit contradicts evidence on doses needed
por: Alison Knopf
Publicado: (2024)

Viloxazine moderate dose associated with good ADHD outcomes
por: Alison Knopf
Publicado: (2024)

Reduce juvenile crime by preventing and treating ACEs
por: Alison Knopf
Publicado: (2024)

FDA urges higher naloxone doses in fentanyl era
por: Alison Knopf
Publicado: (2024)

NIDA starts new study, at infancy, complementary to ABCD
por: Alison Knopf
Publicado: (2024)

CDC: Parents think the kids are alright, but they aren't
por: Alison Knopf
Publicado: (2024)